BioCentury
ARTICLE | Financial News

Curetis raises EUR 12.5M in series B

April 24, 2013 1:05 AM UTC

Molecular diagnostics company Curetis AG (Holzgerlingen, Germany) raised EUR 12.5 million ($16.3 million) in a series B round led by new investor HBM Partners. Existing investors aeris Capital; LSP Life Sciences Partners; Forbion Capital; BioMedInvest; Roche Venture Fund; CD Venture; and KfW also participated. HBM's Alexander Asam will join Curetis' board. ...